Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 35 (3), 341-7

Scoring System for Detecting Spurious Hemolysis in Anticoagulated Blood Specimens


Scoring System for Detecting Spurious Hemolysis in Anticoagulated Blood Specimens

Gilsung Yoo et al. Ann Lab Med.


Background: The identification of in vitro hemolysis (IVH) using a hematology analyzer is challenging because centrifugation of the specimens cannot be performed for cell counts. In the present study, we aimed to develop a scoring system to help identify the presence of hemolysis in anticoagulated blood specimens.

Methods: Thirty-seven potassium EDTA anticoagulated blood specimens were obtained, and each specimen was divided into 3 aliquots (A, B, and C). Aliquots B and C were mechanically hemolyzed by aspirating 2 and 5 times, respectively, using a 27-gauge needle and then tested; aliquot A was analyzed immediately without any hemolysis. After the cells were counted, aliquots B and C were centrifuged and the supernatants were tested for the hemolytic index and lactate dehydrogenase levels.

Results: The 4 hematologic parameters were selected and scored from 0 to 3 as follows:< 34.0, 34.0-36.2, 36.3-38.4, and ≥38.5 for mean cell hemoglobin concentration (MCHC, g/dL); <0.02, 0.02, 0.03, and ≥0.04 for red blood cell ghosts (10(12)/L); <0.13, 0.13-0.38, 0.39-1.30, and ≥1.31 for difference value (g/dL) of measured hemoglobin and calculated hemoglobin; and <0.26, 0.26-0.95, 0.96-3.34, and ≥3.35 for difference value (g/dL) of MCHC and cell hemoglobin concentration mean. The hemolysis score was calculated by adding all the scores from the 4 parameters. At the cutoff hemolysis score of 3, the IVH of aliquots B and C were detected as 64.9% and 91.9%, respectively.

Conclusions: The scoring system might provide effective screening for detecting spurious IVH.

Keywords: Analyzer; Anticoagulants; Hemolysis; Score; System.

Conflict of interest statement

Authors' Disclosures of Potential Conflicts of Interest: No potential conflicts of interest relevant to this article were reported.

Similar articles

See all similar articles

Cited by 1 article

  • ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats.
    Garden OA, Kidd L, Mexas AM, Chang YM, Jeffery U, Blois SL, Fogle JE, MacNeill AL, Lubas G, Birkenheuer A, Buoncompagni S, Dandrieux JRS, Di Loria A, Fellman CL, Glanemann B, Goggs R, Granick JL, LeVine DN, Sharp CR, Smith-Carr S, Swann JW, Szladovits B. Garden OA, et al. J Vet Intern Med. 2019 Mar;33(2):313-334. doi: 10.1111/jvim.15441. Epub 2019 Feb 26. J Vet Intern Med. 2019. PMID: 30806491 Free PMC article.


    1. Clinical Laboratory and Standards Institute. Hemolysis, icterus, and lipemia/turbidity indices as indicators of interference in clinical laboratory analysis. Approved guideline, C56-A. Wayne, PA: Clinical Laboratory and Standards Institute; 2012.
    1. Shin DH, Kim J, Uh Y, Lee SI, Seo DM, Kim KS, et al. Development of an integrated reporting system for verifying hemolysis, icterus, and lipemia in clinical chemistry results. Ann Lab Med. 2014;34:307–312. - PMC - PubMed
    1. Lippi G, Plebani M, Di Somma S, Cervellin G. Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories. Crit Rev Clin Lab Sci. 2011;48:143–153. - PubMed
    1. Vajpayee N, Graham SS, Bem S. Basic examination of blood and bone marrow. In: Henry JB, editor. Clinical diagnosis and management by laboratory methods. 22nd ed. Philadelphia: WB Saunders; 2011. pp. 509–535.
    1. Kunicka J, Malin M, Zelmanovic D, Katzenberg M, Canfield W, Shapiro P, et al. Automated quantitation of hemoglobin-based blood substitutes in whole blood samples. Am J Clin Pathol. 2001;116:913–919. - PubMed

Publication types